| Autologous Redirected RNA Meso-CIR T Cells (NCT01355965) | University of Pennsylvania | 2011-05-01 |
| Stage I/II Nasal NK Cell Lymphoma (NCT01321008) | M.D. Anderson Cancer Center | 2011-05-01 |
| An in Vitro Evaluation of Antimicrobial Photodynamic Therapy on Deciduous Carious Dentin (NCT02479958) | University of Sao Paulo | 2011-05-01 |
| E-health Intervention for Cancer Survivors 2.0 (NCT01348997) | Northwestern University | 2011-05-01 |
| Study of CEP-9722 in Combination With Gemcitabine and Cisplatin in Patients With Advanced Solid Tumors or Mantle Cell Lymphoma (NCT01345357) | Cephalon | 2011-05-01 |
| Evaluation of the Analgesic Effect of Midazolam and Ketamine as an Additive to Intrathecal Bupivacaine in Patients Undergoing Cesarean Section (NCT01404442) | Qazvin University Of Medical Sciences | 2011-05-01 |
| Study of Parenterally Administrated Adjuvanted Seasonal Influenza Vaccine in Healthy Elderly Volunteers (NCT01444482) | Isconova AB | 2011-05-01 |
| Use of IL-15 After Chemotherapy and Lymphocyte Transfer in Metastatic Melanoma (NCT01369888) | National Cancer Institute (NCI) | 2011-05-01 |
| Phase I Study to Investigate the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of CJ-12406 in Healthy Male Subjects (NCT01489774) | HK inno.N Corporation | 2011-05-01 |
| Statin Therapy to Improve Medication Adherence (NCT01894217) | Duke University | 2011-05-01 |
| A Study to Assess if Epanutin Infatabs 50 mg From Germany Are Similar to Dilantin Infatabs 50 mg From Australia (NCT01355068) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2011-05-01 |
| Pharmacokinetic Interaction Study of Glycopyrrolate and Formoterol in Healthy Volunteers (NCT01398111) | Chiesi Farmaceutici S.p.A. | 2011-05-01 |
| BE Study of Torrent's Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Tab - Fed Conditions (NCT02962258) | Torrent Pharmaceuticals Limited | 2011-05-01 |
| A Dose Titration of Droxidopa in Patients With Spinal Cord Injury (NCT01354158) | Bronx VA Medical Center | 2011-05-01 |
| H5N1 Mix and Match With MF59 (NCT01317745) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-05-01 |
| Safety and Efficacy of Adipose Derived Stem Cells for Congestive Heart Failure (NCT01502514) | Ageless Regenerative Institute | 2011-05-01 |
| Study of Applications of Autologous Epidermal Cells in Liquid Phase in the Treatment of Vitiligo (NCT01511965) | Centre Hospitalier Universitaire de Nice | 2011-05-01 |
| Vardenafil ODT (Orally Disintegrating Tablet) - Nifedipine Interaction Study (NCT01348880) | Bayer | 2011-05-01 |
| Immune Response to an HIV DNA Plasmid Vaccine Prime Followed by Adenovirus Boost in HIV-uninfected Individuals (NCT00955006) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-05-01 |
| Development and Pilot Evaluation of a Web-supported Programme of Constraint Induced Therapy Following Stroke (LifeCIT) (NCT01350453) | University of Southampton | 2011-05-01 |
| A Pilot Study of Lithium in Progressive Multiple Sclerosis (NCT01259388) | VA Office of Research and Development | 2011-05-01 |
| Bioequivalence Study of Ondansetron Tablets USP 8 mg Under Fed Condition (NCT01578265) | IPCA Laboratories Ltd. | 2011-05-01 |
| Drug Interaction Study of Isavuconazole and Midazolam (NCT01406171) | Astellas Pharma Inc | 2011-05-01 |
| Intravitreal Ranibizumab Combined With Panretinal Photocoagulation in Patients With Proliferative Diabetic Retinopathy (NCT01746563) | University of Sao Paulo | 2011-05-01 |
| Phase 1b Study of PLX5622 in Rheumatoid Arthritis Patients Who Are Receiving Methotrexate (NCT01329991) | Plexxikon | 2011-05-01 |
| Renal Denervation in Chronic Heart Failure (NCT02146794) | Imperial College London | 2011-05-01 |
| ALK33BUP-201: Safety and Tolerability Study of ALKS 33-BUP (ALKS 5461) Administration in Subjects With MDD (NCT01381107) | Alkermes, Inc. | 2011-05-01 |
| Bioequivalence of Single Dose Phenylephrine Extended Release Tablets and Phenylephrine HCl Immediate Release Tablets Dosed Every Four Hours (P08340)(COMPLETED) (NCT01354418) | Bayer | 2011-05-01 |
| Contribution of Wine Components on Hydroxytyrosol Body Concentrations and Biological Effects (NCT01790672) | Parc de Salut Mar | 2011-05-01 |
| Study Comparing The Tolerability Of Three Excipient Formulations Administered Subcutaneously To Healthy Subjects (NCT01401764) | Ablynx, a Sanofi company | 2011-05-01 |
| Clinical Study of PM01183 in Patients With Acute Leukemia or Relapsed/Refractory Myelodysplastic Syndrome (NCT01314599) | PharmaMar | 2011-05-01 |
| Gene Therapy for WAS (NCT01347346) | Genethon | 2011-05-01 |
| A Study to Evaluate the Immune Response to the ASP7374 and Its Safety in Healthy Adult Volunteers (NCT01393951) | UMN Pharma Inc. | 2011-05-01 |
| Ascending Dose Study of the Safety and Tolerability of Alirocumab (SAR236553/REGN727) in Japanese Healthy Volunteers (NCT01448317) | Sanofi | 2011-05-01 |
| Long Term Safety and Efficacy Study of ProSavin in Parkinson's Disease (NCT01856439) | Axovant Sciences Ltd. | 2011-05-01 |
| Single-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ONO-2952 in Healthy Adult Subjects (NCT01364441) | Ono Pharma USA Inc | 2011-05-01 |
| Single Dose, Dose Escalation Healthy Volunteers Study Of PF-05105679 (NCT01393652) | Pfizer | 2011-05-01 |
| A Study of DNA Vaccine With Electroporation for the Prevention of Disease Caused by H1 and H5 Influenza Virus (NCT01405885) | Inovio Pharmaceuticals | 2011-05-01 |
| A Positron Emission Tomography Study of SLV354 in Healthy Subjects and Subjects With Schizophrenia (NCT01545310) | Abbott | 2011-05-01 |
| Evaluation of a Transrectal Scintigraphic Detector(ProxiScanTM) for Detection of Primary Prostate Cancer (NCT01359189) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2011-05-01 |
| Intraoperative Imaging of Thoracic Malignancies With Indocyanine Green (NCT01335893) | University of Pennsylvania | 2011-05-01 |
| Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 137882 in Healthy Male Volunteers (NCT01348165) | Boehringer Ingelheim | 2011-05-01 |
| Inhaled Xylitol Versus Saline in Stable Subjects With Cystic Fibrosis (NCT01355796) | Joseph Zabner | 2011-05-01 |
| Validation of Instruments for Pragmatic Clinical Trials for Overactive Bladder (NCT01925456) | University of Pennsylvania | 2011-05-01 |
| PK/PD Study of Subcutaneous Cenderitide Infusion in CHF Patients (NCT01316432) | Nile Therapeutics | 2011-05-01 |
| The Effects of Passive Gait Training in Complete Motor Spinal Cord Injury (SCI) (NCT01349478) | Dr. Gabriel Zeilig | 2011-05-01 |
| Lenalidomide in Combination With a Fixed Dose of Sorafenib for the Treatment of Hepatocellular Carcinoma (NCT01348503) | Indiana University | 2011-05-01 |
| Phase 1, Open Label, Two Arm, Fixed Sequence Study to Evaluate the Effect of Rifampin and Rifabutin on GSK1349572 Pharmacokinetics in Healthy Male and Female Volunteers (NCT01231542) | ViiV Healthcare | 2011-05-01 |
| Pulmozyme for Sjogren's Associated Cough (NCT01357447) | UConn Health | 2011-05-01 |
| A Study to Investigate Biomarkers After Single Doses of Anticoagulants in Healthy Young Male and Healthy Elderly Participants (MK-0000-216 AM1) (NCT01379300) | Merck Sharp & Dohme LLC | 2011-05-01 |
| CKD-828 Drug Interaction Study (S-amlodipine) (NCT01356043) | Chong Kun Dang Pharmaceutical | 2011-05-01 |
| Dose-response Study of Exendin-9,39 on Glucose Metabolism (NCT01218633) | Adrian Vella | 2011-05-01 |
| BE of Torrent's Esomeprazole Mg DR Capsules (NCT02680119) | Torrent Pharmaceuticals Limited | 2011-05-01 |
| Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Esomeprazole Magnesium DR Capsules Under Fasting Conditions (NCT02659683) | Torrent Pharmaceuticals Limited | 2011-05-01 |
| Study of an Investigational Drug, ASP3026, in Patients With Solid Tumors (NCT01401504) | Astellas Pharma Inc | 2011-05-01 |
| Safety, Pharmacokinetics, and Pharmacodynamics of MK-6325 in Hepatitis C Virus (HCV) Infections (MK-6325-003) (NCT01329913) | Merck Sharp & Dohme LLC | 2011-05-01 |
| Muscle-Sparing Effect Of Human Chorionic Gonadotropin (hCG) During a Very Low Calorie Diet (VLCD) (NCT02427529) | Dr. Emma's Corporation | 2011-05-01 |
| A Study to Evaluate the Pharmacokinetics of AFQ056 in Subjects With Hepatic Impairment Compared to Healthy Subjects (NCT01456663) | Novartis Pharmaceuticals | 2011-05-01 |
| Effects of Methylnaltrexone in Comparison to Naloxone on Loperamide-induced Delay of the Oro-cecal, Whole-gut and Colon Transit Time. (NCT01596764) | University Medicine Greifswald | 2011-05-01 |
| Study of CA-18C3 in Subjects With Advanced Hematologic Malignancies (NCT01260545) | Janssen Research & Development, LLC | 2011-04-30 |
| A Study to Determine the Excretion Balance and Pharmacokinetics of 14C-GSK573719 (NCT01362257) | GlaxoSmithKline | 2011-04-29 |
| Lenalidomide Maintenance Therapy Post Autologous Transplant for Hodgkins Lymphoma (NCT01207921) | Washington University School of Medicine | 2011-04-28 |
| Sirolimus or Vorinostat and Hydroxychloroquine in Advanced Cancer (NCT01266057) | M.D. Anderson Cancer Center | 2011-04-28 |
| Study of Intraperitoneal Carboplatin With IV Paclitaxel and Bevacizumab in Untreated Ovarian Cancer (NCT01220154) | David O'Malley | 2011-04-28 |
| Study of Oral Ixazomib in Adult Participants With Relapsed or Refractory Light Chain Amyloidosis (NCT01318902) | Millennium Pharmaceuticals, Inc. | 2011-04-27 |
| Hsp90 Inhibitor AUY922 and Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NCT01259089) | Northwestern University | 2011-04-27 |
| Evaluation of Robot Assisted Neuro-Rehabilitation (NCT01253018) | VA Office of Research and Development | 2011-04-27 |
| PU-H71 in Patients With Solid Tumors and Low-Grade Non-Hodgkin's Lymphoma That Have Not Responded to Standard Treatment (NCT01581541) | National Cancer Institute (NCI) | 2011-04-26 |
| Temsirolimus and Cetuximab in Patients With Advanced or Metastatic Solid Tumors (NCT02215720) | Gustave Roussy, Cancer Campus, Grand Paris | 2011-04-26 |
| Safety, Tolerability and Pharmacokinetics of SBC-102 (Sebelipase Alfa) in Adult Participants With Lysosomal Acid Lipase Deficiency (NCT01307098) | Alexion Pharmaceuticals, Inc. | 2011-04-25 |
| BI 6727 (Volasertib) Monotherapy Phase I Trial in Japanese Patients With Advanced Solid Tumours (NCT01348347) | Boehringer Ingelheim | 2011-04-25 |
| Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies. (NCT01353625) | Celgene | 2011-04-25 |
| Clinical Trial of Rapamycin and Irinotecan in Pediatric Patients With Refractory Solid Tumors (NCT01282697) | University Hospital, Strasbourg, France | 2011-04-22 |
| MK2206 in Combination With Anastrozole, Fulvestrant, or Anastrozole and Fulvestrant in Treating Postmenopausal Women With Metastatic Breast Cancer (NCT01344031) | National Cancer Institute (NCI) | 2011-04-21 |
| GSK2251052 Mass Balance in Healthy Adult Subjects (NCT01475695) | GlaxoSmithKline | 2011-04-21 |
| Safety of and Immune Response to Dolutegravir in HIV-1 Infected Infants, Children, and Adolescents (NCT01302847) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-04-20 |
| Study of Pazopanib and Vorinostat in Patients With Advanced Malignancies (NCT01339871) | M.D. Anderson Cancer Center | 2011-04-20 |
| Characterization of [11C]Flumazenil to Image GABA Transmission in Healthy Adult Subjects and Subjects With Alcohol Dependence (NCT01904487) | Rajesh Narendran | 2011-04-19 |
| A Two-part Study of the Effects of MK-1029 in Allergen-Challenged Asthmatics (MK-1029-003) (NCT01343407) | Merck Sharp & Dohme LLC | 2011-04-19 |
| Tumor Cell Vaccines and ISCOMATRIX With Chemotherapy After Tumor Removal (NCT01341496) | National Cancer Institute (NCI) | 2011-04-18 |
| Lamotrigine Bioequivalence Study to Compare Dispersible Tables With Compressed Tablets in China (NCT01357902) | GlaxoSmithKline | 2011-04-18 |
| A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia (NCT01292603) | Hoffmann-La Roche | 2011-04-18 |
| Monotherapy Dose Finding With BI 847325 in Solid Tumours (NCT01324830) | Boehringer Ingelheim | 2011-04-15 |
| A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL) (NCT01077544) | Novartis Pharmaceuticals | 2011-04-14 |
| A Phase I/II Study of Continuous Oral Treatment With BIBF 1120 Added to Standard Gemcitabine/Cisplatin Therapy in First Line NSCLC Patients With Squamous Cell Histology. (NCT01346540) | Boehringer Ingelheim | 2011-04-14 |
| An Extended Feasibility Phase I/II Study of Methylenetetrahydrofolate (Arfolitixorin) and Pemetrexed Single Agent, Given as Neoadjuvant Treatment in Patients With Resectable Rectal Cancer (NCT01397305) | Isofol Medical AB | 2011-04-14 |
| A Study Assessing GW870086's Potential to Cause Skin Thinning (NCT01381445) | GlaxoSmithKline | 2011-04-14 |
| Trial to Determine MTD of BI 836845 Administered Intravenously Once Every Three Weeks in Patients With Advanced Solid Tumours and Later a Weekly Dosing Schedule in Selected Tumour Types (NCT01317420) | Boehringer Ingelheim | 2011-04-13 |
| Safety of NNC 0123-0000-0338 in Healthy Subjects (NCT01334034) | Novo Nordisk A/S | 2011-04-11 |
| Use of Individual Pharmacokinetically (PK)-Guided Sunitinib Dosing: A Feasibility Study in Patients With Advanced Solid Tumors (NCT01286896) | The Netherlands Cancer Institute | 2011-04-11 |
| Psychological Effects of Methylenedioxymethamphetamine (MDMA) When Administered to Healthy Volunteers (NCT01404754) | Resilient Pharmaceuticals | 2011-04-09 |
| Multiple Ascending Dose of BMS-911543 (NCT01236352) | Bristol-Myers Squibb | 2011-04-07 |
| Oral OKT3 for the Treatment of Active Ulcerative Colitis (NCT01287195) | Brigham and Women's Hospital | 2011-04-07 |
| Eltrombopag in Myelodysplastic Syndrome (MDS) Patients With Thrombocytopenia (NCT01286038) | H. Lee Moffitt Cancer Center and Research Institute | 2011-04-06 |
| Cisplatin and Radiation Therapy Followed by Paclitaxel and Carboplatin in Treating Patients With Stage IB-IVA Cervical Cancer (NCT01295502) | Gynecologic Oncology Group | 2011-04-04 |
| Open Label Regorafenib Study to Evaluate Cardiovascular Safety Parameters, Tolerability, and Anti-tumor Activity (NCT01339104) | Bayer | 2011-04-01 |
| Safety and Pharmacokinetics of CBX129801 in Patients With Type 1 Diabetes (NCT01293461) | Cebix Incorporated | 2011-04-01 |
| Safety and Pharmacokinetics of DMUC5754A Administered Intravenously to Patients With Platinum-Resistant Ovarian Cancer or Unresectable Pancreatic Cancer (NCT01335958) | Genentech, Inc. | 2011-04-01 |
| Treatment Of Maxillary Bone Cysts With Autologous Bone Mesenchymal Stem Cells (MSV-H) (NCT01389661) | Red de Terapia Celular | 2011-04-01 |
| Open Label, Single Dose, Non-randomized Study to Assess the Drug to Drug Interaction of Briakinumab on CYP Substrates. (NCT01260844) | Abbott | 2011-04-01 |